Home - Mirum Pharma
Mirum Pharmaceuticals is a high-growth rare disease biopharmaceutical company focused on advancing medicines for cholestatic liver diseases. Founded in 2018 in Foster City, California, the company commercializes LIVMARLI (maralixibat), approved for cholestatic pruritus in Alagille syndrome and progressive familial intrahepatic cholestasis, and is advancing volixibat, an IBAT inhibitor in late-stage development for primary sclerosing cholangitis and additional cholestatic conditions.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountDec 2025
Nov 2018
Create a free account to see which investors have funded this company.
Create Free Account
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Denali Therapeutics is a biotechnology company focused on discovering and developing treatments f...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
